These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31417884)

  • 1. Moving Myeloid Leukemia Drug Discovery Into the Third Dimension.
    Cartledge Wolf DM; Langhans SA
    Front Pediatr; 2019; 7():314. PubMed ID: 31417884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system.
    Alhattab DM; Isaioglou I; Alshehri S; Khan ZN; Susapto HH; Li Y; Marghani Y; Alghuneim AA; Díaz-Rúa R; Abdelrahman S; Al-Bihani S; Ahmed F; Felimban RI; Alkhatabi H; Alserihi R; Abedalthagafi M; AlFadel A; Awidi A; Chaudhary AG; Merzaban J; Hauser CAE
    Biomater Res; 2023 Nov; 27(1):111. PubMed ID: 37932837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development.
    Yao Y; Li F; Huang J; Jin J; Wang H
    Exp Hematol Oncol; 2021 Jul; 10(1):39. PubMed ID: 34246314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Far from Health: The Bone Marrow Microenvironment in AML, A Leukemia Supportive Shelter.
    Sendker S; Waack K; Reinhardt D
    Children (Basel); 2021 May; 8(5):. PubMed ID: 34066861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mimicking the Acute Myeloid Leukemia Niche for Molecular Study and Drug Screening.
    Houshmand M; Soleimani M; Atashi A; Saglio G; Abdollahi M; Nikougoftar Zarif M
    Tissue Eng Part C Methods; 2017 Feb; 23(2):72-85. PubMed ID: 28007011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
    Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
    Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Bone Marrow Microenvironment-Driven Mechanisms of Drug Resistance in Acute Myeloid Leukemia: Tangle or Chance?
    Ciciarello M; Corradi G; Forte D; Cavo M; Curti A
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Myeloid Leukemia and the Bone Marrow Niche-Take a Closer Look.
    Behrmann L; Wellbrock J; Fiedler W
    Front Oncol; 2018; 8():444. PubMed ID: 30370251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies.
    Bruserud Ø; Aasebø E; Hernandez-Valladares M; Tsykunova G; Reikvam H
    Expert Opin Drug Discov; 2017 Oct; 12(10):1053-1065. PubMed ID: 28748730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
    Kogan AA; Lapidus RG; Baer MR; Rassool FV
    Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia.
    Wiggers CRM; Govers AMAP; Lelieveld D; Egan DA; Zwaan CM; Sonneveld E; Coffer PJ; Bartels M
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27785. PubMed ID: 31044544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cellular glutathione and protection by bone marrow stromal cells account for the resistance of non-acute promylocytic leukemia acute myeloid leukemia cells to arsenic trioxide in vivo.
    Lee C; Lin Y; Huang M; Lin C; Liu C; Chow J; Liu HE
    Leuk Lymphoma; 2006 Mar; 47(3):521-9. PubMed ID: 16396776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
    Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
    Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment.
    Isidori A; Salvestrini V; Ciciarello M; Loscocco F; Visani G; Parisi S; Lecciso M; Ocadlikova D; Rossi L; Gabucci E; Clissa C; Curti A
    Expert Rev Hematol; 2014 Dec; 7(6):807-18. PubMed ID: 25227702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting CXCR4/SDF-1 axis by lipopolymer complexes of siRNA in acute myeloid leukemia.
    Landry B; Gül-Uludağ H; Plianwong S; Kucharski C; Zak Z; Parmar MB; Kutsch O; Jiang H; Brandwein J; Uludağ H
    J Control Release; 2016 Feb; 224():8-21. PubMed ID: 26742943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bone marrow microenvironment - Home of the leukemic blasts.
    Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
    Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood and adolescent lymphoid and myeloid leukemia.
    Pui CH; Schrappe M; Ribeiro RC; Niemeyer CM
    Hematology Am Soc Hematol Educ Program; 2004; ():118-45. PubMed ID: 15561680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia.
    Panuzzo C; Signorino E; Calabrese C; Ali MS; Petiti J; Bracco E; Cilloni D
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32188030
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.